We hypothesized that tract-specific abnormalities would correlate with cognitive performance and that these abnormalities, interacting with key AD measures (eg, gray matter atrophy, amyloid and tau positivity), would predict accelerated cognitive decline. Here, MAPT is linked to Mental deterioration.